Breakthrough Therapy Designation granted based on key positive data from the Phase 2b (RIZE) study and current unmet medical need in congenital ...

approval in Australia to initiate a first-in-human phase I therapeutic study of 177Lu-labelled RAD-202 (177Lu-RAD-202) for the treatment of HER2-expressing solid tumors, including breast and gastric ...

In an unprecedented move, America is spearheading the largest mobilization in history with a staggering investment of $75 billion dedicated to developing a robust hydrogen infrastructure. This effort ...

Steven Farram does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...

In a separate announcement, Gilead’s Trodelvy received breakthrough therapy designation from the US Food and Drug Administration (FDA) for treating adults with extensive-stage small cell lung cancer ...

Another innovative approach involves using transgenic mice engineered to produce human ... for the generation of fully human antibodies for a range of therapeutic applications.

Polymyxin B Ointment, a compound renowned for its antibacterial qualities, has the potential to provide therapeutic advantages by promoting ... of the Declaration of Helsinki for research involving ...

India has successfully conducted its first in-human gene therapy for hemophilia A ... a functional gene into the patients' blood stem cells. The therapy enabled the participants to produce Factor VIII ...

People don’t always realize they are creating a human being and not a piece of ... be the beginning of the end for single-use plastic production—but victory over this pollutant isn’t yet ...